Bob Harris wrote: » Are you dollar cost averaging or just averaging down?
DutchYurt wrote: » After an initial large buy I am DCA'ing double the amount of the original buy I bought in so half/half - maybe DCA isnt the correct term in this situation
Bob Harris wrote: » An initial large buy and then you bought in again but double the original amount? DCA'ing is deciding an amount to invest in a company and then spreading out the investment over time at regular intervals. By my understanding you've doubled down after the SP fell following the initial buy. Basically averaging down hoping the price pops so you can let go of the bag you've been holding. Been there, done that, will do again. As for Edesa, I only know of it from your posts on here. A lot more often than not I've found that patience rewards more than trying to trade your way out of trouble. Buffets line about the market being an efficient mechanism to transfer wealth from the impatient to the patient is very true. If you feel Edesa have potential catalysts and nothing fundamental has changed since your initial reason for buying then consider the patience option.
DutchYurt wrote: » Oh sorry, let me explain eg - bought in for 1000 initially, but will buy an additional 2000 more but using the DCA (200 at a time) method if that makes sense! Appreciate the advice - it started to fall when I got in bed with Fastly so ive had alot of red days and my hands are getting weaker! I was just wondering if anyone else was in them to see if they were seeing something I wasn't!
Augeo wrote: » My reasoning is that they are working on treatments that might potentially be used in conjunction with an MSD blockbuster drug. The current SP is tiny relative to that potential. I bought most of my shares at 60% of what they are now so I'm not sitting on a loss and hoping for the best.
RIGOLO wrote: » And AYRO is my EV play , Amazon are building a new distro centre near them and they do electric run abouts.
Timmaay wrote: » NNDM back over 5$ (premarket), I'm very bullish on this company at the minute,they have about a 2year lead on their competitors.https://youtu.be/9xzRymjXLKA
cmssjone wrote: » I’ve done a bit more reading about them. Do you think that they have a realistic chance of joining the NASDAQ? If so, what would the share price increase to? Can definitely see the potential with regards to finding that wonder drug.
bilbot79 wrote: » What do folks think on Tesla? Can it really go much higher than it is now?
RIGOLO wrote: » Investing in bio, esecially bio research companies is ALWAYS high risk but high reward. I took a look at Edesa , my 2 cents , they seem legit, have some products and are targetting a medical sector that has huge demand, so IF they make the breakthrough it will be huge. But their clinical pipeline is all still in either Phase 1 or early Phase 2.. if your expecting regular news updates on these then you will be dissapointed, thats not how those trials work, its slow. Still nothing in Phase 3, so until they get to Phase 3 no one will know how good their product is. If I were you Id be using the FDA trials website to keep track of them, according to that 2 of their trials are still recruiting and the EB01 one seems to be late on reporting, although they recently announced enrollment completion, maybe thats Covid delays, not everythign is up to date.https://clinicaltrials.gov/ct2/results?cond=&term=edesa&cntry=&state=&city=&dist=https://clinicaltrials.gov/ct2/show/NCT03680131?term=eb01+dermatitis&draw=2&rank=1 Seems looks like a young pharma company to me , only 5 years old and only recently completing enrollments so it comes down to have you patience to wait anything from 6 months to 3 years for news and a pop, or do you have so much capital tied up in them you need to get out. Its a small float so they may need another dilution but even so its still a small float. In my experience the first 5 years of any new bio company is spent with all the lab nerd PhDs runing around trying to bonk each other and just happy to have their first job. Once things settle down only then do they crack on with the work. Interesting company, intersting product but its ultimately a bio-pharma punt, needs patience and risk and willingless to lose. Ive lost on plenty of them but others Ive won on so thats the nature of the beast. Welcome to the club your now a bio-pharma venture capitalist Best of luck . Edit : the people involved there seem very expereinced, so I stand corrected on my earlier comment , they are probably well past their days of chasing each other around the lab, and some have a history of developing companies and selling them on, so maybe thats what they are at here, looking for one more payday. And I see a UNC Medical Centre partnership on the EB01 trial. Thats how Id evaluate them and I freely admit Ive invested in bio pharma companies with far less credentials. So it will either end in riches or tears but it may take 3 years before you know for sure.
DutchYurt wrote: » Edesa has dropped below the 5$ resistance with a new low today of 4.89$ and I'll be honest, I'm now starting to worry.. It's been roughly a month since they released news about FDA clearance for Phase 2 so news should be coming soon. I've been saying should alot.. I can't make sense as to why it is still going down, I learned yesterday that a hedge fund bought 120k shares at an avg of 8$ in Q3 (owning about 1.28% of the company) whilst there has been insider buying a few weeks back for 4$ but yet it keeps dripping down. I'll hold my weak hands for now but if it tests the 4.80 level I can't keep DCA'ing from lack of funds so I'll reconsider the advice I read awhile ago of watering the flowers and cutting the weeds at a 30% loss. Any one else thoughts on Edesa?
RIGOLO wrote: » Ive been watching bitcoin chart all week to the point where when I close my eyes I can still see its vague outline. This morning it seems to be holding firm above 18k in a manner not seen before. All bodes well to a green day and Project RIOTMARA as Ive been nibbling at them throughout the week on dips. Looking for relationships and maybe the description of BTC as Gold 2.0 and it being a legitimate haven is coming to fruition.
Cpfm wrote: » +15% as I type.... good call, thanks Timmaay
RIGOLO wrote: » MCPHY (22 euro)- Hydorgen electrolysers , French company, met some of their scientists recently I think they are on the cusp of some breakthrus...
VIX has stabilised but the volatility where previously was across all sectors seems to be more containerised . EVs and all things EV seems to be this weeks VIX toy so lets see if we can play this. The likes of GEVO,AYRO,BLNK,CBAT are all on the radar this morning to see if they are going to run some more.
Shedite27 wrote: » The CEO was on CNBC today talking through Amazon's move. I'm more bullish now after hearing what he had to say, basically that GoodRx still offers far more and bigger discounts than Amazon, and their model is quite different. Up 10% today (still down 20% for the week)
Supercell wrote: » Another day with insane EV runs, had my eye on AYRO yesterday thinking there would be pullback today but now 50% up..lol is all i can say to that! IDEX and GMHI are plays I think that could well explode next week, this is pure gambling though, big risk, big gains